Omnicell Builds Out its Medication Synchronization Platform

People with chronic medical conditions typically take a lot of medications, and it’s not uncommon that many of them skip or forget to take some of their meds as prescribed. A 2011 survey released by the National Consumers League projected that the number of Americans affected by at least one chronic condition requiring medication therapy is expected to reach 157 million by 2020. Into the breach comes Omnicell, Inc. (NASDAQ: OMCL), which provides automation and business analytics software solutions for medication and supply management worldwide. The company announced its acquisition of privately held Ateb, Inc. and its affiliate, Ateb Canada Ltd. on November 29. The... Read More »

Pharma Automation Company Gets $275 Million

Omnicell, Inc. (NASDAQ: OMCL), which provides automation and business analytics solutions for medication and supply management, paid $275 million for Aesynt, a portfolio company of Francisco Partners. Aesynt, which Francisco only acquired in 2013, brings distinct capacities in dispensing systems, central pharmacy robotics, IV robotics and analytics. Aesynt’s robust medication management tools will complement Omnicell’s product portfolio and international footprint. Read More »